SAVA

Cassava Sciences News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Cassava Sciences Inc SAVA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
1.10 9.11% 13.1799 13:54:03
Open Price Low Price High Price Close Price Prev Close
11.75 11.71 13.7805 12.08
more quote information »

Recent News

Date Time Source Heading
1/04/202108:30GLOBECassava Sciences Appoints Dr. James Kupiec as Chief Clinical..
12/14/202017:07EDGARStatement of Changes in Beneficial Ownership (4)
12/14/202017:04EDGARStatement of Changes in Beneficial Ownership (4)
12/11/202016:44EDGARCurrent Report Filing (8-k)
11/27/202008:30GLOBEUSAN Modifies Lead Drug Candidate’s Chemical Name to..
11/23/202010:04EDGARStatement of Ownership (sc 13g)
11/13/202016:37EDGARCurrent Report Filing (8-k)
11/13/202009:08GLOBECassava Sciences Announces Pricing of $75 Million Public..
11/13/202006:10EDGARFree Writing Prospectus - Filing Under Securities Act Rules..
11/13/202006:08EDGARCurrent Report Filing (8-k)
11/12/202016:58EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/12/202016:48GLOBECassava Sciences Announces Proposed Public Offering of..
11/09/202008:30EDGARCurrent Report Filing (8-k)
11/09/202008:15GLOBECassava Sciences Reports Third Quarter 2020 Financial..
11/09/202007:43EDGARQuarterly Report (10-q)
11/04/202017:04EDGARCurrent Report Filing (8-k)
11/04/202008:15GLOBECassava Sciences Announces Additional Clinical Data from a..
9/30/202008:30GLOBECassava Sciences’ Phase 2b Clinical Results in Alzheimer’s..
9/24/202016:50EDGARStatement of Changes in Beneficial Ownership (4)
9/21/202016:02EDGARStatement of Changes in Beneficial Ownership (4)
9/17/202017:26EDGARStatement of Changes in Beneficial Ownership (4)
9/17/202017:16EDGARStatement of Changes in Beneficial Ownership (4)
9/14/202016:03EDGARCurrent Report Filing (8-k)
9/14/202007:15GLOBECassava Sciences Announces Final Results of a Phase 2b..
9/11/202016:01GLOBECassava Sciences to Hold Conference Call on Monday,..
9/10/202016:07EDGARCurrent Report Filing (8-k)
9/09/202008:15GLOBECassava Sciences to Present at H.C. Wainwright’s 22nd Annual..
9/03/202008:15GLOBECassava Sciences Announces New Patent Grant
9/01/202017:01EDGARCurrent Report Filing (8-k)
8/24/202008:15GLOBECassava Sciences Announces Lead Drug Candidate PTI-125 Is..
8/12/202008:30EDGARCurrent Report Filing (8-k)
8/12/202008:15GLOBECassava Sciences Announces Second Quarter 2020 Financial..
7/15/202016:52EDGARCurrent Report Filing (8-k)
7/09/202016:01GLOBECassava Sciences to Give Keynote Presentation on SavaDx at a..
6/19/202016:45EDGARCurrent Report Filing (8-k)
6/16/202008:15GLOBECassava Sciences Added to Russell Indexes and Provides Phase..
6/03/202017:30EDGARCurrent Report Filing (8-k)
6/03/202008:15GLOBECassava Sciences Announces Presentation at the Jefferies..
5/15/202008:21EDGARCurrent Report Filing (8-k)
5/15/202008:15GLOBETop-line Results from a Phase 2b Study of PTI-125 in..
5/11/202016:09EDGARCurrent Report Filing (8-k)
5/06/202016:12EDGARQuarterly Report (10-q)
5/06/202008:17EDGARCurrent Report Filing (8-k)
5/06/202008:15GLOBECassava Sciences Reports First Quarter 2020 Financial..
5/06/202006:02EDGARNotice of Effectiveness (effect)
5/05/202016:40EDGARProspectus Filed Pursuant to Rule 424(b)(2) (424b2)
4/23/202008:15GLOBECassava Sciences Announces New $2.5 Million Research Grant..
4/09/202016:13EDGARSecurities Registration Statement (simplified Form) (s-3/a)
3/27/202017:26EDGARSecurities Registration Statement (simplified Form) (s-3)
3/26/202016:15EDGARProxy Statement (definitive) (def 14a)
See more news about this stock »
Your Recent History
NASDAQ
SAVA
Cassava Sc..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210122 19:09:26